ATE398117T1 - Verbindungen mit antibakteriellen und antiparasitischen eigenschaften - Google Patents
Verbindungen mit antibakteriellen und antiparasitischen eigenschaftenInfo
- Publication number
- ATE398117T1 ATE398117T1 AT00980176T AT00980176T ATE398117T1 AT E398117 T1 ATE398117 T1 AT E398117T1 AT 00980176 T AT00980176 T AT 00980176T AT 00980176 T AT00980176 T AT 00980176T AT E398117 T1 ATE398117 T1 AT E398117T1
- Authority
- AT
- Austria
- Prior art keywords
- antibacterial
- compounds
- sub
- antiparasitic
- antiparasitic properties
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Plural Heterocyclic Compounds (AREA)
- Fodder In General (AREA)
- Quinoline Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9904108A SE9904108D0 (sv) | 1999-11-15 | 1999-11-15 | Nya föreningar |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE398117T1 true ATE398117T1 (de) | 2008-07-15 |
Family
ID=20417705
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00980176T ATE398117T1 (de) | 1999-11-15 | 2000-11-13 | Verbindungen mit antibakteriellen und antiparasitischen eigenschaften |
Country Status (8)
Country | Link |
---|---|
US (1) | US6967205B1 (de) |
EP (1) | EP1230235B1 (de) |
JP (1) | JP2003514812A (de) |
AT (1) | ATE398117T1 (de) |
AU (1) | AU1747201A (de) |
DE (1) | DE60039183D1 (de) |
SE (1) | SE9904108D0 (de) |
WO (1) | WO2001036408A1 (de) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8163769B2 (en) | 2002-03-12 | 2012-04-24 | Abbott Laboratories | Antibacterial compounds |
GB0215775D0 (en) * | 2002-07-06 | 2002-08-14 | Astex Technology Ltd | Pharmaceutical compounds |
BR0314987A (pt) * | 2002-10-11 | 2005-08-09 | Meiji Seika Kaisha | Composição em mistura para o controle de ectoparasitas de manìferos e aves, método para o contrloe de um ectoparasita de mamìferos e aves, combinação, e, uso da mesma |
MXPA05009688A (es) * | 2003-03-12 | 2005-12-05 | Abbott Lab | Derivados de naftiridina como agentes antibacterianos. |
AU2004272414B2 (en) | 2003-09-10 | 2009-05-28 | Kyorin Pharmaceutical Co., Ltd. | 7-(4-substituted 3- cyclopropylaminomethyl-1- pyrrolidinyl) quinolonecarboxylic acid derivative |
US20050124625A1 (en) * | 2003-10-21 | 2005-06-09 | Salvati Mark E. | Piperazine derivatives and their use as modulators of nuclear hormone receptor function |
US7498341B2 (en) * | 2004-01-31 | 2009-03-03 | Sanofi Aventis Deutschland Gmbh | Heterocyclically substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments |
JP2007531775A (ja) * | 2004-03-31 | 2007-11-08 | バイエル・フアーマシユーチカルズ・コーポレーシヨン | 高増殖状態の処置のためのキノロンカルボン酸誘導体 |
US7825122B2 (en) | 2005-12-14 | 2010-11-02 | Amgen Inc. | Diaza heterocyclic sulfonamide derivatives and their uses |
MX2008011633A (es) * | 2006-03-13 | 2008-12-16 | Activx Biosciences Inc | Aminoquinolonas como inhibidores de gsk-3. |
WO2008143343A1 (ja) * | 2007-05-24 | 2008-11-27 | Kyorin Pharmaceutical Co., Ltd. | 14位置換基に複素芳香環カルボン酸構造を有するムチリン誘導体 |
US7902227B2 (en) | 2007-07-27 | 2011-03-08 | Janssen Pharmaceutica Nv. | C-7 isoxazolinyl quinolone / naphthyridine derivatives useful as antibacterial agents |
KR101563018B1 (ko) * | 2007-09-11 | 2015-10-23 | 교린 세이야꾸 가부시키 가이샤 | Gsk-3 억제제로서의 시아노아미노퀴놀론 및 테트라졸로아미노퀴놀론 |
JP5373799B2 (ja) | 2007-09-12 | 2013-12-18 | 杏林製薬株式会社 | Gsk−3阻害剤としてのスピロ環式アミノキノロン |
WO2009090548A2 (en) * | 2008-01-17 | 2009-07-23 | Glenmark Pharmaceuticals, S.A. | 3-azabicyclo [3.1.0] hexane derivatives as vanilloid receptor ligands |
FR2928150A1 (fr) * | 2008-02-29 | 2009-09-04 | Vetoquinol Sa Sa | Nouveaux derives 7-substitues de 3-carboxy-oxadiazino-quinolones, leur preparation et leur application comme anti-bacteriens |
AU2010221990B2 (en) | 2009-03-11 | 2015-06-04 | Kyorin Pharmaceutical Co., Ltd. | 7-cycloalkylaminoquinolones as GSK-3 inhibitors |
CN102030737B (zh) * | 2010-10-29 | 2014-03-26 | 重庆巴仕迪动物药业有限公司 | 克林沙星氨基衍生物及其应用 |
WO2013142628A2 (en) * | 2012-03-20 | 2013-09-26 | Fred Hutchinson Cancer Research Center | Antibiotic compounds and compositions, and methods for identification thereof |
US8877931B2 (en) * | 2012-08-03 | 2014-11-04 | Gilead Sciences, Inc. | Process and intermediates for preparing integrase inhibitors |
JP2017538689A (ja) * | 2014-11-17 | 2017-12-28 | ニーロジョン セラピューティクス インコーポレイテッドNirogyone Therapeutics, Inc. | モノカルボン酸輸送修飾薬およびその使用 |
JP2018528260A (ja) * | 2015-07-28 | 2018-09-27 | ビオーム バイオサイエンシズ プライベート リミティド | 抗菌性治療薬及び予防薬 |
DE102017218119A1 (de) * | 2017-10-11 | 2019-04-11 | Christian-Albrechts-Universität Zu Kiel | In der Umwelt abbaubare Chinolon-Antibiotika mit Hemiaminal-Struktureinheit |
CN108484577B (zh) * | 2018-03-05 | 2021-03-30 | 复旦大学 | 一种嘧啶-喹诺酮类杂合物及其制备方法和用途 |
CN111087409B (zh) * | 2018-10-24 | 2021-06-08 | 江阴安博生物医药有限公司 | 一种喹诺酮类化合物及其制备方法和应用 |
CA3122106C (en) * | 2018-12-18 | 2024-05-28 | Elanco Tiergesundheit Ag | Bicyclic derivatives |
CN109942546B (zh) * | 2019-04-16 | 2022-04-08 | 西南大学 | 喹诺酮嘧啶类化合物及其制备方法和应用 |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1598915A (en) | 1977-09-20 | 1981-09-23 | Bellon Labor Sa Roger | 1,4-dihydro-quinoline-3-carboxylic acid derivatives process for their preparation and composition containing them |
JPS5630964A (en) * | 1979-08-22 | 1981-03-28 | Kyorin Pharmaceut Co Ltd | Novel substituted quinolinecarboxylic acid and its preparation |
GB2093018B (en) | 1979-08-22 | 1984-09-12 | Kyorin Seiyaku Kk | 6,8-difluoro-quinoline carboxylic acid derivatives |
JPS5746986A (en) * | 1980-09-02 | 1982-03-17 | Dai Ichi Seiyaku Co Ltd | Pyrido(1,2,3-de)(1,4)benzoxazine derivative |
DE3033157A1 (de) | 1980-09-03 | 1982-04-01 | Bayer Ag, 5090 Leverkusen | 7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-naphthyridin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel |
DE3142854A1 (de) * | 1981-10-29 | 1983-05-11 | Bayer Ag, 5090 Leverkusen | 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7-piperazino-chinolin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel |
NZ208470A (en) | 1983-07-18 | 1988-06-30 | Abbott Lab | 6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid derivatives and antibacterial compositions containing such |
AU553415B2 (en) | 1983-09-19 | 1986-07-17 | Abbott Japan Co., Ltd. | 6-fluoro-1-4-dihydro-4-oxo-7-substituted piperazinyl- quinoline-3-carboxylic acids |
EP0154780B1 (de) * | 1984-01-26 | 1990-04-11 | Abbott Laboratories | Antibakterielle Chinolinderivate |
IT1173374B (it) | 1984-02-24 | 1987-06-24 | Mediolanum Farmaceutici Srl | Derivati pirido-benzotiazinici ad elevata attivita' antimicrobica |
DE3608745A1 (de) | 1985-07-24 | 1987-01-29 | Bayer Ag | Bakterizide zubereitungen zur anwendung auf dem gebiet der veterinaermedizin |
DE3632222A1 (de) * | 1986-09-23 | 1988-04-07 | Bayer Ag | Topisch anwendbare zubereitungen von gyrase-inhibitoren |
DE3637649A1 (de) * | 1986-10-13 | 1988-04-14 | Uwe Dr Spohr | Verwendung von 4-chinolon-derivaten zur bekaempfung von protozoen und helminthen |
DE3639465A1 (de) | 1986-11-18 | 1988-05-19 | Hoechst Ag | Optisch aktive gyrasehemmer, ihre herstellung und verwendung als antibiotika |
MY104139A (en) | 1988-08-09 | 1994-02-28 | Daiichi Seiyaku Co | Antimicrobial agent for animals |
US5225413A (en) | 1988-09-16 | 1993-07-06 | Bayer-Aktiengesellschaft | pH-neutral aqueous solutions of quinolone-carboxylic acids |
US5164402A (en) | 1989-08-16 | 1992-11-17 | Pfizer Inc | Azabicyclo quinolone and naphthyridinone carboxylic acids |
US5266569A (en) | 1989-08-16 | 1993-11-30 | Pfizer Inc. | Azatricyclo carboxylic acids useful as anti-bacterial agents |
FR2674854B1 (fr) * | 1991-04-04 | 1995-03-03 | Bouchara | Nouvelles quinolones leur procede de preparation et les compositions pharmaceutiques en refermant. |
US5395936A (en) * | 1993-06-04 | 1995-03-07 | Manzo; Ruben H. | 7-(4-[4-aminophenyl)sulphonyl]-1-piperazinyl fluorquinolonic derivatives and synthesis |
DK0676199T3 (da) | 1994-04-07 | 1999-02-08 | Pfizer | Anvendelse af trovafloxacin eller derivater deraf til fremstilling af et medikament til behandling af H. pylori-infektione |
DE19519822A1 (de) | 1995-05-31 | 1996-12-05 | Bayer Ag | Neue antibakterielle Mittel |
-
1999
- 1999-11-15 SE SE9904108A patent/SE9904108D0/xx unknown
-
2000
- 2000-11-13 DE DE60039183T patent/DE60039183D1/de not_active Expired - Fee Related
- 2000-11-13 WO PCT/SE2000/002217 patent/WO2001036408A1/en active Application Filing
- 2000-11-13 JP JP2001538897A patent/JP2003514812A/ja active Pending
- 2000-11-13 AU AU17472/01A patent/AU1747201A/en not_active Abandoned
- 2000-11-13 US US10/111,898 patent/US6967205B1/en not_active Expired - Fee Related
- 2000-11-13 AT AT00980176T patent/ATE398117T1/de not_active IP Right Cessation
- 2000-11-13 EP EP00980176A patent/EP1230235B1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP1230235A1 (de) | 2002-08-14 |
WO2001036408A1 (en) | 2001-05-25 |
JP2003514812A (ja) | 2003-04-22 |
SE9904108D0 (sv) | 1999-11-15 |
EP1230235B1 (de) | 2008-06-11 |
US6967205B1 (en) | 2005-11-22 |
DE60039183D1 (de) | 2008-07-24 |
AU1747201A (en) | 2001-05-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE398117T1 (de) | Verbindungen mit antibakteriellen und antiparasitischen eigenschaften | |
EG25017A (en) | N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobials. | |
YU46303A (sh) | 6-0-karbamoil ketolidni derivati eritromicina korisni kao antibakterijska sredstva | |
SE9900100D0 (sv) | New compounds | |
DE60214591D1 (en) | Pyrazolpyrimidinfungizide | |
BG106390A (en) | Novel spiro compounds | |
SE0004245D0 (sv) | Novel compounds and their use | |
BG108498A (en) | New derivatives of oxazolidinones as antibacterial agents | |
MXPA04006041A (es) | Antivirales de piridoquinoxalina. | |
BR0316086A (pt) | N-sulfonil-4-metileno amino-3-hidróxi-2-piridonas como agente microbicida | |
TR200302288T2 (tr) | Terapi için yeni bileşikler ve metotlar. | |
EA200500353A1 (ru) | Производные линкомицина, обладающие антибактериальной активностью | |
MXPA04001419A (es) | Isoxazolopiridinonas y su uso en el tratamiento de enfermedad de parkinson. | |
HK1062172A1 (en) | Biguanide derivatives | |
BR0012751A (pt) | Benzofuranos serotonérgicos | |
CA2380455A1 (en) | 9a-azalides with antibacterial activity | |
ATE223226T1 (de) | Azazyklohexapeptid-verbindungen | |
DE60005517D1 (de) | Kaliumkanal-blockierende mittel | |
TR199901017A2 (xx) | B�cek ilac� terkibi. | |
GB0103240D0 (en) | Organic compounds | |
ATE276259T1 (de) | Dihydroporphyrinderivate und ihre verwendung | |
DK1244614T3 (da) | Tryptase-inhibitorer | |
EA200600092A1 (ru) | Новые цитотоксические депсипептиды | |
WO2004094370A3 (en) | Antibacterial pyrazole carboxylic acid hydrazides | |
ES2355624T8 (es) | Pirrolidinohidroquinazolinas. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |